Literature DB >> 21740524

Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.

Eleni A Karavia1, Dionysios J Papachristou, Ioanna Kotsikogianni, Ioanna Giopanou, Kyriakos E Kypreos.   

Abstract

Apolipoprotein E (apoE) mediates the efficient catabolism of the chylomicron remnants very low-density lipoprotein and low-density lipoprotein from the circulation, and the de novo biogenesis of high-density lipoprotein. Lipid-bound apoE is the natural ligand for the low-density lipoprotein receptor (LDLr), LDLr-related protein 1 and other scavenger receptors. Recently, we have established that deficiency in apoE renders mice resistant to diet-induced obesity. In the light of these well-documented properties of apoE, we sought to investigate its role in the development of diet-induced nonalcoholic fatty liver disease (NAFLD). apoE-deficient, LDLr-deficient and control C57BL/6 mice were fed a western-type diet (17.3% protein, 48.5% carbohydrate, 21.2% fat, 0.2% cholesterol, 4.5 kcal·g(-)) for 24 weeks and their sensitivity to NAFLD was assessed by histological and biochemical methods. apoE-deficient mice were less sensitive than control C57BL/6 mice to diet-induced NAFLD. In an attempt to identify the molecular basis for this phenomenon, biochemical and kinetic analyses revealed that apoE-deficient mice displayed a significantly delayed post-prandial triglyceride clearance from their plasma. In contrast with apoE-deficient mice, LDLr-deficient mice fed a western-type diet for 24 weeks developed significant accumulation of hepatic triglycerides and NAFLD, suggesting that apoE-mediated hepatic triglyceride accumulation in mice is independent of LDLr. Our findings suggest a new role of apoE as a key peripheral contributor to hepatic lipid homeostasis and the development of diet-induced NAFLD.
© 2011 The Authors Journal compilation © 2011 FEBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740524     DOI: 10.1111/j.1742-4658.2011.08238.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  18 in total

1.  Adrenoceptor-related decrease in serum triglycerides is independent of PPARα activation.

Authors:  Maria Konstandi; Kyriakos E Kypreos; Tsutomu Matsubara; Eva Xepapadaki; Yatrik M Shah; Kristopher Krausz; Christina E Andriopoulou; Aristeidis Kofinas; Frank J Gonzalez
Journal:  FEBS J       Date:  2019-06-28       Impact factor: 5.542

2.  H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Authors:  Vineesh V Raveendran; Karen M Kassel; Donald D Smith; James P Luyendyk; Kurt J Williams; Rachel Cherian; Gregory A Reed; Colleen A Flynn; Iván L Csanaky; Andrew L Lickteig; Matthew J Pratt-Hyatt; Curtis D Klaassen; Kottarappat N Dileepan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

3.  Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.

Authors:  Xiaoying Liu; Anne S Henkel; Brian E LeCuyer; Matthew J Schipma; Kristy A Anderson; Richard M Green
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-15       Impact factor: 4.052

4.  S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.

Authors:  Maite Martínez-Uña; Marta Varela-Rey; Daniela Mestre; Larraitz Fernández-Ares; Olatz Fresnedo; David Fernandez-Ramos; Virginia Gutiérrez-de Juan; Idoia Martin-Guerrero; Africa García-Orad; Zigmund Luka; Conrad Wagner; Shelly C Lu; Carmelo García-Monzón; Richard H Finnell; Igor Aurrekoetxea; Xabier Buqué; M Luz Martínez-Chantar; José M Mato; Patricia Aspichueta
Journal:  J Hepatol       Date:  2014-10-18       Impact factor: 25.083

5.  Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Hui-Ling Xu
Journal:  Mol Biol Rep       Date:  2012-07-04       Impact factor: 2.316

6.  The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides.

Authors:  Foteini Malliou; Ioanna Andreadou; Frank J Gonzalez; Antigone Lazou; Eva Xepapadaki; Ioanna Vallianou; George Lambrinidis; Emmanuel Mikros; Marios Marselos; Alexios-Leandros Skaltsounis; Maria Konstandi
Journal:  J Nutr Biochem       Date:  2018-06-05       Impact factor: 6.048

7.  Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice.

Authors:  Eleni A Karavia; Dionysios J Papachristou; Kassiani Liopeta; Irene-Eva Triantaphyllidou; Odyssefs Dimitrakopoulos; Kyriakos E Kypreos
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

8.  The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations.

Authors:  Caterina Constantinou; Diogenis Mpatsoulis; Anastasios Natsos; Peristera-Ioanna Petropoulou; Evangelia Zvintzou; Abdulmaged M Traish; Peter J Voshol; Iordanes Karagiannides; Kyriakos E Kypreos
Journal:  J Lipid Res       Date:  2014-05-15       Impact factor: 5.922

9.  Lipoprotein metabolism in nonalcoholic fatty liver disease.

Authors:  Zhenghui Gordon Jiang; Simon C Robson; Zemin Yao
Journal:  J Biomed Res       Date:  2012-12-01

10.  Aging decreases antioxidant effects and increases lipid peroxidation in the Apolipoprotein E deficient mouse.

Authors:  Taro Honma; Tsuyoshi Tsuduki; Soko Sugawara; Yasuna Kitano; Junya Ito; Ryo Kijima; Mari Tsubata; Kiyotaka Nakagawa; Teruo Miyazawa
Journal:  J Clin Biochem Nutr       Date:  2013-04-09       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.